Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million ...

GlaxoSmithKline Consumer Healthcare - Sri Lanka, (GSK), makers of Panadol is constructing a new Panadol production plant which will be located next to its present pharmaceutical operation at Moratuwa.

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

GSK boss Emma Walmsley is selling the company's consumer healthcare division, which makes big-brand products including Sensodyne and Panadol. That move is designed to let it focus on developing ...

Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

The objective was to raise awareness of the product and triple its effectiveness. We showed Panadol's understanding of tough people and their tough pain. We showcased interesting and likeable people ...

Haleon was formed in 2022 from a combination of GSK Plc and Pfizer’s consumer-health units. The company makes a wide range of products, including Panadol pain relief tablets and Centrum vitamins. GSK ...

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

Pfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 ...